# MI Care

> MI Care is a VC fund backing Medical, Pharmaceutical and Health Diagnostics. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Total investments: 3
- Last investment: Jan 2018
- Lead investor: 0%
- Last updated: Aug 2026

MI Care is a VC fund focused on Medical and Pharmaceutical. MI Care S.A. is a private investment company, incorporated in the Great Duchy of Luxembourg. Its management has more than 20 years' experience investing in healthcare and biotechnology companies.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 33% |
| Pharmaceutical | 1 | 33% |
| Health Diagnostics | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 1 | 33% |
| Private Equity | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| HalioDx | HalioDx designs and develops diagnostic tests in oncology utilizing the immune contexture of cancers. | $20.3M | Series B | Jan 17, 2018 |  |
| Advicenne Pharma SA | Advicenne is a specialty pharmaceutical company dedicated to improving the lives of patients who suffer from rare renal diseases. | $17.6M | Private Equity | Mar 20, 2017 |  |
| Advicenne | Since its founding in 2007, Advicenne has been dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephrology. Our lead drug candidate, ADV7103, is in late-stage clinical trials for two indications: distal renal tubular acidosis (dRTA) and cystinuria. Listed on both the Euronext Parisand Euronext Brussels stock exchanges, the company is headquartered in Nîmes, France. | $18.2M | Private Equity | Mar 20, 2017 |  |

3 of 3 investments shown.

## Co-investors
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 2 deals together
- [Cemag Invest](https://shizune.co/investors/profile/cemag-invest) — VC Fund, 2 deals together
- [InnoBio](https://shizune.co/investors/profile/innobio) — VC Fund, 2 deals together
- [IRDI SORIDEC Gestion](https://shizune.co/investors/profile/irdi-soridec-gestion) — VC Fund, 2 deals together
- [IXO Private Equity](https://shizune.co/investors/profile/ixo-private-equity) — VC Fund, 2 deals together
- [BNP Paribas Développement](https://shizune.co/investors/profile/bnp-paribas-developpement) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does MI Care invest in?

MI Care invests primarily in Medical, Pharmaceutical and Health Diagnostics startups, most often at Series B and Private Equity stage. Most of the 3 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did MI Care last invest?

The most recent investment recorded for MI Care closed in Jan 2018. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co